Skip to main content

Table 2 Person-days and crude incidence rates of diabetes among initiators of angiotensin receptor blockers

From: Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

 

Losartan

Valsartan

Irbesartan

Candesartan

Telmisartan

Olmesartan

Exposed person-days

160,956,721

252,964,999

115,243,240

44,349,122

46,800,437

26,163,756

Mean follow-up days

1263.57

1378.66

1425.48

1124.76

1336.51

992.22

Mean treatment duration (days)

312.03

349.32

379.50

344.67

329.76

271.00

Mean daily dosage (DDD)

0.36

0.39

0.39

0.41

0.42

0.37

Number of newly diagnosed diabetes

16,227

25,849

11,436

4,371

4,666

2,809

Crude incidence rate per 1,000,000 person-days (95% CI)

100.82 (99.26-102.37)

102.18 (100.94-103.43)

99.23 (97.41-101.05)

98.56 (95.64-101.48)

99.70 (96.84-102.56)

107.36 (103.39-111.33)